AI Science Tracker

Two molecules against KRAS from a hybrid AI and quantum process

University of Toronto; and Insilico Medicine · 27 Jan 2025 · medicine

Discovery

Two molecules against KRAS from a hybrid AI and quantum process

A process combining quantum and classical computing with Chemistry42 selected 15 candidates; two showed activity against mutated KRAS variants in living cells. Published in Nature Biotechnology, this is a proof of principle, with no significant quantum advantage or demonstrated superiority over compounds obtained by classical methods.

Technology: Chemistry42 and hybrid quantum-classical models

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Fifteen candidates from the hybrid process were tested in the lab, and two strongly targeted mutated KRAS variants in living cells.
  • Still unknown: The source states it is a proof-of-principle study with no significant quantum advantage and no demonstrated superiority over classically designed molecules.
  • AI role: Generative AI (Chemistry42) and a quantum-classical process designed molecules, narrowed to 15 candidates.

Evidence sources: https://www.utoronto.ca/news/ai-quantum-computing-used-target-undruggable-cancer-protein

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: press release. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 125 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.